Shibayama, Y., Kameda, H., Ota, S., Tsuchida, K., Cho, K. Y., Nakamura, A., . . . Atsumi, T. (2019). Case of fulminant type 1 diabetes induced by the anti‐programmed death‐ligand 1 antibody, avelumab. J Diabetes Investig.
Citação norma ChicagoShibayama, Yui, Hiraku Kameda, Shoichiro Ota, Kazuhisa Tsuchida, Kyu Yong Cho, Akinobu Nakamura, Hideaki Miyoshi, and Tatsuya Atsumi. "Case of Fulminant Type 1 Diabetes Induced By the Anti‐programmed Death‐ligand 1 Antibody, Avelumab." J Diabetes Investig 2019.
Citação norma MLAShibayama, Yui, et al. "Case of Fulminant Type 1 Diabetes Induced By the Anti‐programmed Death‐ligand 1 Antibody, Avelumab." J Diabetes Investig 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.